Paratek Pharmaceuticals
Paratek Pharmaceuticals is a commercial‑stage biopharmaceutical company focused on innovative tetracycline‑derived antibiotics such as NUZYRA and SEYSARA. It is dedicated to combating antimicrobial resistance and developing therapies for serious public‑health threats.
Address: 1000 First Avenue, Suite 200, King of Prussia, PA 19406
Phone: (617) 807-6600
-
Paratek Pharmaceuticals Approves Buyout Deal; No Plans to Close King of Prussia Office
The shareholders of the Boston biopharmaceutical company Paratek Pharmaceuticals have voted to accept a $462 million buyout, writes John George…
-
Pharmaceutical Company with King of Prussia Offices Goes Private in New Deal
Paratek Pharmaceuticals, which is based in Boston but has offices in King of Prussia, is turning private after being a…
-
Positive Clinical Trial Results Bumps Paratek’s Stock Up 23%
Paratek Pharmaceuticals, the Boston biotech company with operations in King of Prussia, recently saw its stock soar 23 percent to…
-
Paratek Pharmaceuticals Expands KoP Office Ahead of Hiring Spree
While Paratek Pharmaceuticals is headquartered in Boston, the company’s expansion is currently focused on its King of Prussia office which…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
